Original Research

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

Stefanos Giannopoulos, MD¹; Eric A. Secemsky, MD²; Peter A. Schneider, MD³; Ehrin J. Armstrong, MD¹

Reprinted with permission from J Invasive Cardiol 2022;34(6):E469-E476.

August 2022

Reprinted with permission from J Invasive Cardiol 2022;34(6):E469-E476.

Click here to read the study.

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Endovascular Devices

Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)

03/19/2026

New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...

New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...

New Britain, PA, March 16, 2026...

03/19/2026

Vascular Disease Management

Neurovascular acquisitions

Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care

03/11/2026

Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.

Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.

Scientia's novel access platform...

03/11/2026

Cath Lab Digest

EggNest (Egg Medical)

Clinical Trial Update

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

03/10/2026

"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...

"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...

"By using the EggNest system, we...

03/10/2026

EP Lab Digest

CathWorks FFRangio

Fractional Flow Reserve

Late-Breaking Trial: U.S. Cohort of 4,000+ CathWorks FFRangio Patients Shows 2-Year Outcomes Comparable to Pressure Wire–Guided PCI

03/08/2026

"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...

"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...

"This first look at contemporary...

03/08/2026

Cath Lab Digest

Heart Failure

BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)

03/04/2026

Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...

Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...

Dr. Amish Raval reported that...

03/04/2026

Cath Lab Digest

Heart Failure

Relief Cardiovascular Reports Positive First-in-Human Data for Device-Based Decongestion Therapy in Heart Failure Patients

03/04/2026

"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...

"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...

"The RELIEF-FIH study provides...

03/04/2026

Cath Lab Digest

Amputation Prevention

Researchers Develop New Oxygen-Delivering Gel Designed to Help Wounds Heal Before They Progress to Limb Loss

02/23/2026

A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...

A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...

A wound that remains open for...

02/23/2026

Cath Lab Digest

Nutrition

People Whose Sugar Intake Was Restricted Before Birth and In Early Childhood Had Markedly Lower Rates of Heart Disease Later In Life

02/23/2026

Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...

Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...

Limiting sugar consumption...

02/23/2026

Cath Lab Digest

VentiV Mechanical Thrombectomy system illustration

Thrombectomy

FDA Clearance for VentiV Mechanical Thrombectomy System Brings New “Pulse” Platform to Peripheral Clot Removal

02/23/2026

SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...

SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...

SALT LAKE CITY, UT ...

02/23/2026

Cath Lab Digest

Acute Coronary Syndromes

Acute Coronary Events Registry Provides Insights Into Sex-Specific Differences

02/20/2026

Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...

Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...

Munich, Germany – Preliminary...

02/20/2026

Cath Lab Digest